There’s a big change coming for asthma sufferers, starting on January 1. On Monday, Flovent, a widely used asthma inhaler made by GSK, will no longer be available in U.S. pharmacies. In its place will ...

A groundbreaking international study has shown that a 2-in-1 budesonide-formoterol inhaler is far more effective than the standard salbutamol inhaler in children with mild asthma, cutting attacks by ...

A new study suggests that many patients aren’t waiting between puffs on their inhalers and may not be deriving the full benefits of the drugs. By Perri Klass, M.D. Asthma is the most common chronic ...

SAN ANTONIO – It’s common knowledge that diabetics receive their insulin through injections or pumps. However, many people don’t know of a new option: inhalable insulin. The inhaler called Afrezza, ...